Lisa Wang

Also affiliated with Icahn School of Medicine at Mount Sinai

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials”.

Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab015

N/A

0.612DataRank · unranked

58 citations

Daniel Shepshelovich, Christina Gallagher, Lisa Wang, Albiruni R. Abdul Razak, Anna Spreafico +5 more

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer

Nature Communications(2022)10.1038/s41467-022-33172-5

N/A

0.550DataRank · unranked

38 citations

Xueping Qu, Chu-Fang Lin, Ling‐Yuh Huw, Avinashnarayan Venkatanarayan, Ethan Sokol +14 more

A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6010

N/A

0.510DataRank · unranked

29 citations

Daniela Matei, Panagiotis A. Konstantinopoulos, Matthew S. Block, Andrea Jewell, Stéphanie Gaillard +15 more

Brain malformations and seizures by impaired chaperonin function of TRiC

Science(2024)10.1126/science.adp8721

N/A

0.489DataRank · unranked

25 citations

Piere Rodriguez-Aliaga, Weimin Yuan, Lena Franken, Kamil K. Zajt, Dimah Hasan +82 more

A randomized phase II study of bevacizumab and weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory ovarian cancer NCI trial#10150.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5514

N/A

0.470DataRank · unranked

22 citations

Husam Alqaisi, David E. Cohn, Jing‐Yi Chern, Linda Duska, Andrea Jewell +15 more

Data sharing in the PRIMED Consortium: Design, implementation, and recommendations for future policymaking

The American Journal of Human Genetics(2025)10.1016/j.ajhg.2025.06.004

N/A

0.301DataRank · unranked

5 citations

Quenna Wong, Whitney Hornsby, Matthew P. Conomos, Iftikhar J. Kullo, Bruce M Psaty +28 more

Patient self-reporting of tolerability using PRO-CTCAE: A randomized double-blind placebo controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in women with platinum resistant epithelial ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5541

N/A

0.208DataRank · unranked

3 citations

Sandra A. Mitchell, Tyler Pittman, Lisa Wang, Valerie Bowering, Nisan Kavak +9 more

Autism risk variants in DLG4 ortholog increase penetrance of uncommon individual behavioral trait in Caenorhabditis elegans

PubMed(2025)10.17912/micropub.biology.001781

N/A

0DataRank · unranked

0 citations

Lauren Rosta, Paula Hernández, Swetha Iyer, Lisa Wang, Audrey C. Brumback +2 more